Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Generation Bio Co. (NQ: GBIO )

2.180 -0.140 (-6.03%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 78,629
Open 2.320
Bid (Size) 2.060 (1)
Ask (Size) 3.090 (1)
Prev. Close 2.320
Today's Range 2.160 - 2.325
52wk Range 0.8600 - 4.830
Shares Outstanding 66,741,175
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
GBIO Stock Earnings: Generation Bio Misses EPS, Beats Revenue for Q2 2024
GBIO stock results show that Generation Bio missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Generation Bio Reports Second Quarter 2024 Financial Results
Cash balance of $217 million still expected to fund operations into 2H 2027 
From Generation Bio Co.
Via GlobeNewswire

Performance

YTD
+17.20%
+17.20%
1 Month
-9.17%
-9.17%
3 Month
-27.09%
-27.09%
6 Month
-31.88%
-31.88%
1 Year
-52.81%
-52.81%

More News

Read More
Generation Bio to Present at the Canaccord Genuity 44th Annual Growth Conference
From Generation Bio Co.
Via GlobeNewswire
Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit
From Generation Bio Co.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
GBIO Stock Earnings: Generation Bio Misses EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results
From Generation Bio Co.
Via GlobeNewswire
Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual Meeting
From Generation Bio Co.
Via GlobeNewswire
Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
From Generation Bio Co.
Via GlobeNewswire
Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference
From Generation Bio Co.
Via GlobeNewswire
GBIO Stock Earnings: Generation Bio Misses EPS, Beats Revenue for Q4 2023
Via InvestorPlace
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
From Generation Bio Co.
Via GlobeNewswire
Generation Bio to Present at the 2024 TD Cowen Health Care Conference
From Generation Bio Co.
Via GlobeNewswire
Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Generation Bio Co.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms
From Generation Bio Co.
Via GlobeNewswire
Why Direct Digital Shares Are Trading Higher By Around 33%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Generation Bio Reports Business Highlights and Third Quarter 2023 Financial Results
From Generation Bio Co.
Via GlobeNewswire
Generation Bio Announces Demonstration of Highly Selective T Cell Transduction In Vivo with Cell-Targeted LNP Platform
From Generation Bio Co.
Via GlobeNewswire
Top 4 Health Care Stocks That May Rocket Higher This Month
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Nasdaq Falls 100 Points; AT&T Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Why Nokia Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.